Skip to main content
Alan  Ramsay

Professor Alan Ramsay

Professor of Cancer Immunology

Research interests

  • Cancer
  • Immunology

Biography

Alan G. Ramsay is Professor of Cancer Immunology, leading the Lymphoma Immunology research group within the Comprehensive Cancer Centre at King’s College London. He studied Zoology at Glasgow and Molecular Microbiology at Nottingham, completing his PhD in Molecular and Cell Biology at Aberdeen following a research placement in Lausanne, Switzerland.

His Cancer Research UK postdoctoral training at Barts Cancer Institute linked integrin trafficking to carcinoma migration and invasion. He subsequently pioneered research revealing how blood cancers disrupt immune synapses, the specialised contacts through which immune cells recognise and attack tumour cells, and demonstrated how immunomodulatory drugs can restore their function.

Since joining King’s, his group has uncovered how cancer reprogrammes lymph node fibroblasts to create immunosuppressive tumour microenvironments. His research in blood and lung cancers focuses on understanding and overcoming immune evasion, translating laboratory discoveries into clinical trials and developing more effective cancer immunotherapies.

    Research

    Alan Ramsay Lab: Lymphoma Immunology

    The Alan Ramsay Lab: Lymphoma Immunology research group is led by Professor Alan G. Ramsay, Professor of Cancer Immunology at King's College London.

    Immunometabolism (iMet) Research Interest Group (RIG)

    The aim of the i-met research interest group is to stimulate novel collaborations in the field of Immunometabolism, a young but rapidly growing field of research.

    News

    Drug mechanism opens door for new anti-cancer immunotherapies

    Researchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukaemia, through the promotion of immune cell...

    t cells

    Targeting the tumour environment could improve immunotherapy responses for lymphoma patients, study reveals

    Researchers have shown how the cancer lymphoma reprogrammes cells key to our immune responses, leading them to shift to immunosuppressive activity

    Lymphoma picture

    Researchers identify a combination therapy approach to help cold tumours respond to immunotherapy

    The discovery marks an important step for patients with chronic lymphocytic leukemia.

    cold tumours

    Events

    11Nov

    Inaugural Lectures: Professors Andrea Billè & Alan Ramsay

    Inspiring talks from two of our new professors about their work, their specialisations, and their journeys to where they are today.

    Please note: this event has passed.

      Research

      Alan Ramsay Lab: Lymphoma Immunology

      The Alan Ramsay Lab: Lymphoma Immunology research group is led by Professor Alan G. Ramsay, Professor of Cancer Immunology at King's College London.

      Immunometabolism (iMet) Research Interest Group (RIG)

      The aim of the i-met research interest group is to stimulate novel collaborations in the field of Immunometabolism, a young but rapidly growing field of research.

      News

      Drug mechanism opens door for new anti-cancer immunotherapies

      Researchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukaemia, through the promotion of immune cell...

      t cells

      Targeting the tumour environment could improve immunotherapy responses for lymphoma patients, study reveals

      Researchers have shown how the cancer lymphoma reprogrammes cells key to our immune responses, leading them to shift to immunosuppressive activity

      Lymphoma picture

      Researchers identify a combination therapy approach to help cold tumours respond to immunotherapy

      The discovery marks an important step for patients with chronic lymphocytic leukemia.

      cold tumours

      Events

      11Nov

      Inaugural Lectures: Professors Andrea Billè & Alan Ramsay

      Inspiring talks from two of our new professors about their work, their specialisations, and their journeys to where they are today.

      Please note: this event has passed.